DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Mendell J, Johnson L, Ridout G, He L, Chen S.
An open-label phase 1 study to evaluate the effects of hepatic impairment on edoxaban pharmacokinetics.
Eur Heart J 2012;
33 (S1): Abstract 2024
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.